Astellas Pharma (United States)

1.3k papers and 30.8k indexed citations i.

About

In recent decades, authors affiliated with Astellas Pharma (United States) have published 1.3k papers, which have received a total of 30.8k indexed citations. Scholars at this organization have produced 312 papers in Pulmonary and Respiratory Medicine, 238 papers in Oncology and 228 papers in Epidemiology on the topics of Prostate Cancer Treatment and Research (173 papers), Antifungal resistance and susceptibility (122 papers) and Urinary Bladder and Prostate Research (109 papers). Their work is cited by papers focused on Pulmonary and Respiratory Medicine (7.3k citations), Epidemiology (6.6k citations) and Oncology (5.5k citations). Authors at Astellas Pharma (United States) collaborate with scholars in United States, Japan and United Kingdom and have published in prestigious journals including New England Journal of Medicine, The Lancet and Journal of Clinical Oncology. Some of Astellas Pharma (United States)'s most productive authors include Peter L. Bonate, Nkechi Azie, Laura Kovanda, Daniel P. Petrylak, James Spalding, M. Roy First, Neal D. Shore, Jonathan E. Rosenberg, Christopher Lademacher and Nancy Martin.

In The Last Decade

Fields of papers published by authors at Astellas Pharma (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Astellas Pharma (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Astellas Pharma (United States) at the time of their publication.

Countries citing scholars working at Astellas Pharma (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Astellas Pharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Astellas Pharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astellas Pharma (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Institute for Research and Innovation in Biomedicine Breakdown of academic impact, for scholars at Fukui Prefectural University Breakdown of academic impact, for scholars at PSA Peugeot Citroën (France) Breakdown of academic impact, for scholars at Pirkanmaa Hospital District Breakdown of academic impact, for scholars at Florida Department of Health Breakdown of academic impact, for scholars at Institut de Chimie de Clermont-Ferrand Breakdown of academic impact, for scholars at Institute of Metal Superplasticity Problems Breakdown of academic impact, for scholars at Guangzhou Regenerative Medicine and Health Guangdong Laboratory